Supply Chain Intelligence

Inovio Pharmaceuticals, Inc. Supply Chain

INO supply chain intelligence for Inovio Pharmaceuticals, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

INO ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

1Suppliers
5Customers
3Debt Items
20Related Chains

Inovio Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
OPPENHEIMER-CO-INC OPPENHEIMER-CO-INC 92% The Company notified Oppenheimer & Co. Inc. (the “Sales Agent”) that it was suspending and terminating the prospectus, dated August 13, 2024

Inovio Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
APOLLOBIO APOLLOBIO 92% During the years ended December 31, 2025 and 2024, we derived 100% of our revenue from ApolloBio.
GOVERNMENT GOVERNMENT 90% A small number of licensing partners and government contracts have accounted for a substantial portion of our revenue.
LICENSING-PARTNERS LICENSING-PARTNERS 90% A small number of licensing partners and government contracts have accounted for a substantial portion of our revenue.
OPPENHEIMER-CO-INC OPPENHEIMER-CO-INC 90% the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, through the Sales Agent
VXRT Vaxart, Inc. 72% Reciprocal relationship from VXRT graph: irements relating to the organization of personnel, buildings and facilities, equipment, control of components and drug product containers and closures, produ…

Inovio Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
INO-DEBT Debt stack $8.7M 90% Market cache reports total debt of $8.7M.
INO-DEBT-10295 Warrants outstanding: 681625 90% xbrl warrant detail from xbrl 2025-12-31.
INO-DEBT-10296 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.

Inovio Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Inovio Pharmaceuticals, Inc..

Inovio Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
INO-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 101 tracked holders.

Inovio Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
GRDX GridAI Technologies Corp. 100.00 2
View INO supply chain intel →

Explore the full interactive supply chain map for Inovio Pharmaceuticals, Inc..

Open INO supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map